Annual D&A
$6.91 M
+$5.53 M+398.70%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual depreciation & amortization is currently $6.91 million, with the most recent change of +$5.53 million (+398.70%) on 31 December 2023. During the last 3 years, it has risen by +$6.84 million (+9500.00%). BHVN annual D&A is now at all-time high.BHVN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.99 M
+$40.00 K+2.05%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly depreciation & amortization is currently $1.99 million, with the most recent change of +$40.00 thousand (+2.05%) on 30 September 2024. Over the past year, it has increased by +$456.00 thousand (+29.65%). BHVN quarterly D&A is now -58.65% below its all-time high of $4.82 million, reached on 01 December 2020.BHVN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$7.29 M
+$456.00 K+6.67%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM depreciation & amortization is currently $7.29 million, with the most recent change of +$456.00 thousand (+6.67%) on 30 September 2024. Over the past year, it has increased by +$1.93 million (+35.92%). BHVN TTM D&A is now -22.85% below its all-time high of $9.45 million, reached on 01 December 2020.BHVN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +398.7% | +29.6% | +35.9% |
| 3 y3 years | +9500.0% | - | - |
| 5 y5 years | +2469.5% | +854.1% | +1028.2% |
BHVN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +9500.0% | at high | +697.6% | at high | +2815.2% |
| 5 y | 5 years | at high | +9500.0% | -58.6% | +854.1% | -22.9% | +2815.2% |
| alltime | all time | at high | +9500.0% | -58.6% | >+9999.0% | -22.9% | >+9999.0% |
Biohaven Pharmaceutical Holding Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.99 M(+2.0%) | $7.29 M(+6.7%) |
| June 2024 | - | $1.95 M(+35.1%) | $6.83 M(+1.8%) |
| Mar 2024 | - | $1.45 M(-23.7%) | $6.71 M(-2.9%) |
| Dec 2023 | $6.91 M(+398.7%) | $1.89 M(+23.1%) | $6.91 M(+28.9%) |
| Sept 2023 | - | $1.54 M(-16.0%) | $5.36 M(+27.6%) |
| June 2023 | - | $1.83 M(+11.0%) | $4.20 M(+50.8%) |
| Mar 2023 | - | $1.65 M(+379.4%) | $2.79 M(+100.9%) |
| Dec 2022 | $1.39 M(-0.5%) | $344.00 K(-8.8%) | $1.39 M(+33.0%) |
| Sept 2022 | - | $377.00 K(-9.2%) | $1.04 M(+56.7%) |
| June 2022 | - | $415.00 K(+66.0%) | $665.00 K(+166.0%) |
| Mar 2022 | - | $250.00 K(-94.8%) | $250.00 K(-97.4%) |
| Dec 2021 | $1.39 M(+1834.7%) | - | - |
| Dec 2020 | $72.00 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | - | $4.82 M(+56.9%) | $9.45 M(+95.4%) |
| Sept 2020 | - | $3.07 M(+133.6%) | $4.83 M(+120.0%) |
| June 2020 | - | $1.32 M(+460.0%) | $2.20 M(+149.4%) |
| Mar 2020 | - | $235.00 K(+12.4%) | $881.00 K(+36.4%) |
| Dec 2019 | $646.00 K(+140.1%) | - | - |
| Dec 2019 | - | $209.00 K(-52.2%) | $646.00 K(+47.8%) |
| Sept 2019 | - | $437.00 K(<-9900.0%) | $437.00 K(<-9900.0%) |
| Dec 2018 | $269.00 K | - | - |
| June 2017 | - | -$4000.00(-200.0%) | -$1000.00(-133.3%) |
| Mar 2017 | - | $4000.00(-300.0%) | $3000.00(>+9900.0%) |
| Dec 2016 | - | -$2000.00(-300.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $1000.00(>+9900.0%) | $2000.00(+100.0%) |
| June 2016 | - | $0.00(-100.0%) | $1000.00(0.0%) |
| Mar 2016 | - | $1000.00 | $1000.00 |
FAQ
- What is Biohaven Pharmaceutical Holding annual depreciation & amortization?
- What is the all time high annual D&A for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual D&A year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly D&A year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM depreciation & amortization?
- What is the all time high TTM D&A for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM D&A year-on-year change?
What is Biohaven Pharmaceutical Holding annual depreciation & amortization?
The current annual D&A of BHVN is $6.91 M
What is the all time high annual D&A for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual depreciation & amortization is $6.91 M
What is Biohaven Pharmaceutical Holding annual D&A year-on-year change?
Over the past year, BHVN annual depreciation & amortization has changed by +$5.53 M (+398.70%)
What is Biohaven Pharmaceutical Holding quarterly depreciation & amortization?
The current quarterly D&A of BHVN is $1.99 M
What is the all time high quarterly D&A for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly depreciation & amortization is $4.82 M
What is Biohaven Pharmaceutical Holding quarterly D&A year-on-year change?
Over the past year, BHVN quarterly depreciation & amortization has changed by +$456.00 K (+29.65%)
What is Biohaven Pharmaceutical Holding TTM depreciation & amortization?
The current TTM D&A of BHVN is $7.29 M
What is the all time high TTM D&A for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM depreciation & amortization is $9.45 M
What is Biohaven Pharmaceutical Holding TTM D&A year-on-year change?
Over the past year, BHVN TTM depreciation & amortization has changed by +$1.93 M (+35.92%)